Published in Medical Letter on the CDC and FDA, July 13th, 2003
The vaccine, called FluMist (MedImmune Vaccines, Inc.), was approved June 17, 2003, by the FDA for healthy people ages 5 to 49, but not for people who often are in most need of protection from the flu: toddlers, the elderly, and people with asthma or some other chronic diseases.
For children 5 to 8, the first exposure to FluMist requires 2 doses 6 weeks apart. Patients ages 9 to 49 need only 1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA